<VariationArchive VariationID="635342" VariationName="NM_020435.4(GJC2):c.591dup (p.His198fs)" VariationType="Duplication" Accession="VCV000635342" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2019-07-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="623125" VariationID="635342">
      <GeneList>
        <Gene Symbol="GJC2" FullName="gap junction protein gamma 2" GeneID="57165" HGNC_ID="HGNC:17494" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="228149930" stop="228159826" display_start="228149930" display_stop="228159826" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="228337414" stop="228347526" display_start="228337414" display_stop="228347526" Strand="+" />
          </Location>
          <OMIM>608803</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020435.4(GJC2):c.591dup (p.His198fs)</Name>
      <CanonicalSPDI>NC_000001.11:228158347:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q42.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="228158347" stop="228158348" display_start="228158347" display_stop="228158348" variantLength="1" positionVCF="228158347" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="228346048" stop="228346049" display_start="228346048" display_stop="228346049" variantLength="1" positionVCF="228346048" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>H198fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.228346050dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.228346050dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.228158349dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.228158349dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011838.1" sequenceAccession="NG_011838" sequenceVersion="1" change="g.13498dup">
            <Expression>NG_011838.1:g.13498dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020435.4" sequenceAccession="NM_020435" sequenceVersion="4" change="c.591dup" MANESelect="true">
            <Expression>NM_020435.4:c.591dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065168.2" sequenceAccession="NP_065168" sequenceVersion="2" change="p.His198fs">
            <Expression>NP_065168.2:p.His198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020435.3" sequenceAccession="NM_020435" sequenceVersion="3" change="c.591dupA">
            <Expression>NM_020435.3:c.591dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1455411788" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020435.4(GJC2):c.591dup (p.His198fs) AND Pelizaeus-Merzbacher disease" Accession="RCV000790418" Version="1">
        <ClassifiedConditionList TraitSetID="3066">
          <ClassifiedCondition DB="MedGen" ID="C0205711">Pelizaeus-Merzbacher disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-15" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020435.4(GJC2):c.591dup (p.His198fs) AND Spastic paraplegia" Accession="RCV002536883" Version="2">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-24" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-07-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15192806</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31319225</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3066" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3286" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pelizeaus-Merzbacher spectrum disorder</ElementValue>
                <XRef ID="MONDO:0010714" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pelizaeus Merzbacher brain sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pelizaeus-Merzbacher disease</ElementValue>
                <XRef ID="Pelizaeus-Merzbacher+disease/5643" DB="Genetic Alliance" />
                <XRef ID="64855000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudanophilic leukodystrophy</ElementValue>
                <XRef ID="HP:0003269" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PMD</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PLP1-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLP1 disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Heterozygous females may manifest mild-to-moderate signs of the disease.</Attribute>
                <XRef ID="NBK1182" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4265" />
                <XRef ID="4265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301361</ID>
                <ID Source="BookShelf">NBK1182</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="702" DB="Orphanet" />
              <XRef ID="C0205711" DB="MedGen" />
              <XRef ID="MONDO:0010714" DB="MONDO" />
              <XRef Type="MIM" ID="312080" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003269" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1810092" SubmissionDate="2019-05-19" DateLastUpdated="2019-07-27" DateCreated="2019-07-27">
        <ClinVarSubmissionID localKey="INHP_185|Pelizaeus-Merzbacher disease" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000925656" DateUpdated="2019-07-27" DateCreated="2019-07-27" Type="SCV" Version="1" SubmitterName="Ege University Pediatric Genetics, Ege University" OrgID="506131" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31319225</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020435.3:c.591dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Pelizaeus-Merzbacher disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31319225</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31319225</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB5623890</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6144373" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="400526|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003455825" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15192806</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31319225</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GJC2 protein in which other variant(s) (p.Arg240*) have been determined to be pathogenic (PMID: 15192806; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 635342). This premature translational stop signal has been observed in individual(s) with Pelizaeus-Merzbacher disease (PMID: 31319225). This sequence change creates a premature translational stop signal (p.His198Thrfs*66) in the GJC2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 242 amino acid(s) of the GJC2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.228346048_228346049insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1810092" TraitType="Disease" MappingType="Name" MappingValue="Pelizaeus-Merzbacher disease" MappingRef="Preferred">
        <MedGen CUI="C0205711" Name="Pelizaeus-Merzbacher disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6144373" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

